Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
17,716
Total Claims
$1.1M
Drug Cost
615
Beneficiaries
$1,776
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-90%
Opioid rate vs peers
0.2% vs 2.6% avg
+66%
Cost per patient vs peers
$1,776 vs $1,068 avg
+44%
Brand preference vs peers
13.0% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
0.2%
Opioid Rate
44
Opioid Claims
$119
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 2,279 claims · $767K
Generic: 15,283 claims · $323K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 466 | $252K |
| Rivaroxaban | 194 | $100K |
| Linagliptin | 154 | $78K |
| Tiotropium Bromide | 90 | $44K |
| Budesonide/Formoterol Fumarate | 114 | $29K |
| Insulin Glargine,hum.Rec.Anlog | 54 | $24K |
| Sacubitril/Valsartan | 35 | $23K |
| Ticagrelor | 52 | $22K |
| Irbesartan | 103 | $21K |
| Insulin Aspart Prot/Insuln Asp | 65 | $16K |
| Insulin Glargine,hum.Rec.Anlog | 33 | $13K |
| Insulin Aspart | 38 | $12K |
| Dabigatran Etexilate Mesylate | 42 | $11K |
| Cyclosporine | 15 | $11K |
| Levothyroxine Sodium | 284 | $10K |
Prescribing Profile
Patient Profile
77
Avg Age
55%
Female
2.05
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About